enVVeno Medical (NVNO) Asset Utilization Ratio (2018 - 2019)
enVVeno Medical's (NVNO) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2019, down 83.6% year-on-year from 0.04 in Q4 2018, and down 28.32% quarter-over-quarter from 0.01 in Q3 2019.
enVVeno Medical (NVNO) Asset Utilization Ratio (2018 - 2019) Analysis & Trends
enVVeno Medical's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.01 for Q4 2019.
- On a quarterly basis, Asset Utilization Ratio fell 83.6% year-over-year to 0.01 in Q4 2019; TTM through Dec 2019 was 0.01, a 83.6% decrease from a year earlier, with the FY2019 full-year figure at 0.01, down 86.17% from the prior year.
- Asset Utilization Ratio declined to 0.01 in Q4 2019 per NVNO's latest filing, from 0.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.05 in Q3 2018 and bottomed at 0.01 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.02 |
| Mar 31, 2019 | 0.04 |
| Dec 31, 2018 | 0.04 |
| Sep 30, 2018 | 0.05 |